News
Metabiote® protocol is now GCLP compliant
Metabiote®, the reference protocol in targeted metagenomics developed by GenoScreen, is now GCLP compliant.
Molecular identification of microorganisms
Molecular identification of microorganisms, to strengthen health and food safety.
A major advance in the fight against multidrug-resistant tuberculosis
Deeplex®-MycTB, was used in a study published in The Lancet Infectious Diseases highlighting the spread of tuberculosis strains resistant to first-line antibiotics, not detected by current diagnostic tests.
The Deeplex-MycTB solution presented in Les Echos
Check out the Les Echos article on our innovative Deeplex-MycTB solution, a next-generation test for combating multidrug-resistant TB.
Improving, through the genomic approach, the diagnosis, monitoring and follow-up of polluted sites: the conclusions of the BioDISSPOL project
GenoScreen will present the conclusions of the BioDISSPOL project on November 28 at Pollutec Lyon during the panel discussion: "Microbial Biomarkers : Application to the diagnosis and management of polluted sites".
GenoScreen in La Gazette of Nord-Pas de Calais
Discover La Gazette Nord-Pas de Calais article about our company "GenoScreen dissects DNA"
Discover Deeplex-MycTB
Discover Deeplex-MycTB, a next-generation molecular analysis solution that allows, in a single test,
- to identify the mycobacteria of the M. tuberculosis complex causing tuberculosis,
- to predict their resistance to multiple antibiotics of first and second intent
- and to type them for epidemiological surveillance purposes.
Become a GenoScreen Team Member
Join the GenoScreen team, we are looking for a Technical Sales Engineer, Genomics Specialty, apply!